Conclusions: A high percentage of patients presented with gross or occult gastrointestinal bleeding with or without abdominal pain. Endoscopic biopsy is necessary for diagnosis. Steroid was the mainstay treatment for active diseases; montelukast was also effective for the disease or as a maintenance therapy in this study.
Introduction
Eosinophilic gastroenteritis is characterized by eosinophil infiltrations of the gastrointestinal tract, resulting in variable symptoms. 1 First described in 1937 by Kaijser, 2 its actual incidence is difficult to estimate. Klein et al 3 reported the concept of classification by the different layers involved: predominant mucosal, muscle layer, and subserosal diseases. The most common affected sites are the stomach and proximal intestine, 4 although it can affect any area of the gastrointestinal tract from esophagus to rectum. The pathogenesis is not fully understood, and it is still considered as an allergic mechanism. 5 Clinical manifestations depend on the involved sites and layers. Patients with eosinophilic gastroenteritis may present with abdominal pain, nausea, vomiting, diarrhea, weight loss, gastrointestinal bleeding, intestinal malabsorption, or ascites. 6, 7 Eosinophilic gastroenteritis can be observed in any age group, but reports in the pediatric group are rare. 8 Other causes of intestinal eosinophilia, including parasite infection, 9e11 inflammatory bowel disease, 12 collagen vascular disease, 13 or malignancy, should be ruled out before the diagnosis of eosinophilic gastroenteritis is confirmed. Peripheral blood eosinophilia and food allergy are not always necessary for the diagnosis, 4,14 but they may be the initial clue. Elevated Immunoglobulin E (IgE) can be observed in some cases. The presence of eosinophilic infiltration in biopsy specimen is supportive of eosinophilic gastroenteritis. Previous studies showed limited data in pediatric group, and most of the patients in those studies were treated with corticosteroid. 8 Some case reports showed effective results of montelukast therapy, but longterm prognosis was lacking. 15, 16 Eosinophilic gastroenteritis in Asian children has not been reported. In our study, we reviewed our experience in the past 12 years of eosinophilic gastroenteritis with regard to clinical course, laboratory features, treatment response, and prognosis.
Materials and Methods
Between 1997 and 2009, 14 patients (nine boys and five girls from 12 families, aged 1.4e14.3 years) were diagnosed as having eosinophilic gastroenteritis in the Department of Pediatrics, National Taiwan University Hospital. The median age at symptom onset was 7.5 years (0.3e14 years). The ages of diagnosis were all greater than 1 year to distinguish the diagnosis from cow's milk protein allergy in infancy. We set the criteria of diagnosis as follows: (1) the presence of gastrointestinal symptoms; (2) an increased eosinophilic infiltration in the gastrointestinal tract on a biopsy specimen; and (3) peripheral eosinophilia (>600 cells/mL). Patients were diagnosed as having "definite eosinophilic gastroenteritis" if they met Criteria (1) and (2) and other patients as having "probable eosinophilic gastroenteritis" when Criteria (1) and (3) were met. The exclusion criteria included inflammatory bowel disease, parasite infection, neoplasm, collagen vascular disease, and Churg-Strauss syndrome. The initial manifestations; the onset and duration of symptoms before diagnosis; history of allergy; family history of allergy (defined as asthma, atopy, and drug allergy or food intolerance); endoscopic findings; pathological results; and duration of follow-up were analyzed. Patients were defined as steroid dependent when they had partial or complete response to steroid use, and the symptoms could be controlled only by continuous use of corticosteroid. The laboratory data included peripheral eosinophil count, erythrocyte sedimentation rate, serum IgE concentrations, and serum albumin. Increased eosinophilic infiltration in the gastrointestinal tract was defined as more than 20 eosinophils per one high-power field under microscopic examination, which was interpreted by a single experienced pathologist blinded to the previous investigations. Seven patients had received allergen-specific IgE testing (ImmunoCap; Pharmacia Diagnostics AB, Uppsala, Sweden). The treatment and prognosis, including episodes of relapse and the duration of steroid tapering, were analyzed.
Statistical analysis
The STATA software package (StataCorp LP, College Station, TX, USA) was used for statistical analysis. Mann-Whitney U test was used for continuous variables. Statistical significance was assumed with p < 0.05.
Results

Clinical and laboratory results
Fourteen patients were diagnosed with eosinophilic gastroenteritis according to our criteria. The median age at time of diagnosis was 8.3 years (range, 1.4e14.3 years). The median duration from onset of symptoms to diagnosis was 3 months (range, 0.2e36 months). The initial symptoms included abdominal pain, anemia, hypoalbuminemia, recurrent vomiting, and bloody stool. Table 1 reveals the general characteristics and laboratory results of our patients. Half of the patients (7 of 14) presented with gross or occult hematochezia, and a high percentage of patients had significant anemia with hemoglobin (Hb) < 8 mg/dL (5 of 14, 36%). Peripheral eosinophilia (>600 cells/mL) was present in 10 patients (71.4%) at initial diagnosis, and the median absolute eosinophil count in serum was 1011 counts/mL (range, 167e15,605).
History of atopy was noticed in four (4 of 14, 28.6%) patients, including asthma and allergic rhinitis. One-third of patients (three of nine, 33.3%) who received allergenspecific IgE testing were allergic to multiple foods, and twothirds (six of nine, 66.7%) of the patients had elevated levels of serum IgE. The median level of serum IgE was 1285 IU/mL (range, 3.81e3947 IU/mL). Forty-five percent of the patients had serum albumin levels less than 3.5 g/dL. The median level of serum albumin was 4.4 g/dL (range, 1.9e5.0 g/dL). Elevated erythrocyte sedimentation rate was noted only in two patients. All patients had normal growth (body weight and body height) before diagnosis and treatment according to the reference range for Taiwanese children, except one patient below the age-and gendermatched third percentile.
Endoscopic and histological findings
Endoscopic examination was performed in all patients, and four of the 14 patients (28.6%) received microscopic examination more than once because of nonspecific findings in the beginning. One patient proceeded to intraoperative enteroscopy because of suspected ileal bleeding according to red blood cell bleeding scan. The endoscopic examination revealed ulcer disease in four patients (4 of 14, 28.6%) and a negative finding in one patient (1 of 14, 7.1%) ( Table 2 ). The other nine patients (9 of 14, 64.3%) had nonspecific findings in their endoscopic examination, including gastritis and duodenitis. The most common site involved was the stomach, followed by duodenum and colon ( Figure 1 ). Multiple biopsy samples were taken at various sites, including the esophagus, stomach, small intestine, and colon, before the definite diagnosis was made (Figure 2) . The median number of biopsy specimen taken from the gastrointestinal tract was 5.5 (range, 2e14).
Tissue eosinophilia versus nontissue eosinophilia
We categorized our 14 patients into two groups, as shown in Table 3 . Nine out of 14 patients (64.3%) were grouped into definite eosinophilic gastroenteritis when they met the criteria of tissue eosinophilia (>20 eosinophils per high power field, 40Â magnification level). In this group, four did not have peripheral eosinophilia. The tissue eosinophilia in five patients (five of nine, 55.6%) was found at different sites of the gastrointestinal tract. The other five patients were grouped into probable eosinophilic gastroenteritis because they only had peripheral eosinophilia without tissue eosinophilia. We compared the age at diagnosis, duration of symptoms before diagnosis, biopsy numbers, endoscopic finding, serum eosinophil count, and relapse episodes between the two groups. Patients with definite eosinophilic gastroenteritis had a lower age at 
Treatment and prognosis
The treatment regimens included corticosteroid, montelukast, and ketotifen ( 
Discussion
Eosinophilic gastroenteritis is a rare disease in children, characterized by eosinophil infiltration in the gastrointestinal tract, resulting in abdominal symptoms. Diagnosis is sometimes difficult and should be made with combination of the pathology and clinical manifestations. Peripheral eosinophilia is the initial clue for diagnosis but is not always present in eosinophilic gastroenteritis. 4, 14 In our study, onethird of the patients did not have peripheral eosinophilia. Interestingly, anemia with or without apparent gastrointestinal bleeding was an important symptom, present in onethird of our patients. Furthermore, half of our patients had positive stool occult blood in the beginning, although they may not have had gastrointestinal discomfort. The high incidence of anemia in patients with eosinophilic gastroenteritis may be because of its recognizable features, such as pale appearance or easy fatigue. Parents or clinicians will be more alert to the symptoms and proceed to endoscopic examinations. The actual incidence of eosinophilic gastroenteritis may be higher because those patients with minor symptoms and without anemia may be underdiagnosed.
Once the eosinophilic gastroenteritis is suspected, endoscopic examination should be arranged. The histological evidence may be more reliable when making the diagnosis, but negative histological findings cannot exclude the possibility of eosinophilic gastroenteritis. Because eosinophilic infiltration is usually patchy in distribution, multiple sites of biopsy should be obtained to avoid missing the diagnosis. 17 In our patients, the biopsy specimen at one site revealed normal appearance, whereas another specimen at a different site had very significant tissue eosinophilia. These findings implied that some patients with suspected eosinophilic gastroenteritis should not be excluded from this diagnosis even with normal histological result. In our study, patients without tissue eosinophilia seemed to have smaller biopsy numbers.
The real pathogenesis of eosinophilic gastroenteritis is not fully understood, and heterogenous causes may be responsible for this disease. The hypothesis of IgE-mediated food allergy has been accepted for a long time. 18 The occasional coexistence of eosinophilic gastroenteritis and atopic disorders, such as asthma, eczema, or allergic rhinitis, may support this theory, 19 but low proportion of allergy history was also reported in other studies. 4, 20 Recently, the mechanism of cell-mediated hypersensitivity was also presented by some authors. 21, 22 This may explain why the result of allergen-specific IgE testing was negative in most of the patients. In our study, only 28.6% of patients had an atopic history, which made the history less helpful in establishing the diagnosis. Only three patients in our study were proved to have a specific food allergy by allergen-specific IgE test. Patient No. 14 was allergic to chocolate and eggs; thus, avoidance of these foods was recommended. We did not give her medication except diet elimination and followed up her Hb and stool occult blood. Her Hb level gradually returned to normal, and stool occult blood disappeared after 1 month. However, for those patients with multiple food allergies, food avoidance is not always practical. Talley et al 4 reported that a past history of allergy was found in 50% of the eosinophilic gastroenteritis patients in their study. Eighty percent of the patients had a coexisting atopic disease, such as asthma, eczema, or allergic rhinoconjunctivitis, in a world-wide-web-based registry. 23 Because atopic disease is highly prevalent in Taiwan and about 5.6e8.1% of school children had a history of asthma, 24 we suspect that eosinophilic gastroenteritis may be more prevalent than previously reported. A prospective, large-scale study is mandated to actually analyze the incidence of eosinophilic gastroenteritis.
Three of our patients were siblings (one elder brother, patient No. 3, and two younger sister patients, No. 4 and 5) coming from one family. All of them presented with epigastralgia as initial manifestation, and two had an atopic history. In one report, two siblings presenting with severe iron-deficiency anemia and hypoalbuminemia were both diagnosed with eosinophilic gastroenteritis. 25 There has 7 Only one out of 17 patients became steroid dependent. In our study, 10 patients had a smooth treatment course (10 of 14, 71.4%) and three patients (3 of 14, 21.4%) had difficulty in tapering steroid. Corticosteroid is rapidly effective in symptom relief but carries the risk of immunity suppression, increased susceptibility to infections, osteoporosis, growth failure, and mood or endocrine disorders when used on a long-term basis. 32e34 According to previous studies, a leukotriene antagonist may be a good alternative maintenance therapy for steroid-dependent patients. In our study, three patients treated with a leukotriene antagonist alone had good outcome without relapse during follow-up. This result gives us an additional option in eosinophilic gastroenteritis, especially in steroiddependent patients. More randomized trials are required to assess the long-term benefits and side effects of a leukotriene antagonist in eosinophilic gastroenteritis.
In conclusion, eosinophilic gastroenteritis in children is a rare disease, and its prevalence may be underestimated in those patients not receiving endoscopic examinations because of nonspecific symptoms or minor diseases. A high index of suspicion is essential when the patient has peripheral eosinophilia, positive stool occult blood, and anemia. Endoscopic examination is necessary, and multiple biopsy specimens should be taken. Steroid is the main therapy in the acute stage, but montelukast may be a good alternative therapy for minor diseases and as a long-term maintenance treatment. 
